Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU
- PMID: 15288311
- DOI: 10.1016/j.ijantimicag.2004.01.015
Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU
Abstract
Antibiotic resistance is a major and well-known problem in intensive care units (ICUs) world-wide and previously susceptible isolates become resistant through the acquisition of resistance determinants from other bacteria or the development of mutations, as is the case in beta-lactam resistance. We evaluated the presence of resistance determinants involved in beta-lactam resistance and multi-resistance in order to establish the contribution of horizontal gene transfer to the spread of resistance in a surgical ICU during an antibiotic rotation study. Pseudomonas aeruginosa and Enterobacteriaceae isolates were selected and iso-electric focusing (IEF), DNA-typing methods such as specific beta-lactamase and specific integron PCRs were performed to determine the presence of beta-lactamases. The PCRs specific for IMP-1, OXA-1, and VIM-type beta-lactamases performed on the selected P. aeruginosa and Enterobacteriaceae isolates with MICs for cephalosporins >1 mg/l did not demonstrate any of these beta-lactamases. IEF for 14 pseudomonads, representing 7 genotypes from 9 patients, showed a beta-lactamase with a pI larger than 8.5 in 13 of the isolates. The integrase PCR was positive for only five isolates from three patients and conserved segment PCR showed integrons of variable sizes (700, 900, 1,400 and 1,500 bp). Each patient had its own integron types. It can be concluded that integrons and associated resistance determinants played only a minor role in the surgical ICU and beta-lactam resistance among P. aeruginosa isolates was most likely due to the derepression of its AmpC gene.
Similar articles
-
Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.J Antimicrob Chemother. 2006 Sep;58(3):530-6. doi: 10.1093/jac/dkl266. Epub 2006 Jul 1. J Antimicrob Chemother. 2006. PMID: 16816399
-
Unnoticed spread of integron-carrying Enterobacteriaceae in intensive care units.Clin Infect Dis. 2005 Jul 1;41(1):1-9. doi: 10.1086/430711. Epub 2005 May 26. Clin Infect Dis. 2005. PMID: 15937755
-
Integrons and beta-lactamases--a novel perspective on resistance.Int J Antimicrob Agents. 2004 Jun;23(6):556-62. doi: 10.1016/j.ijantimicag.2004.03.007. Int J Antimicrob Agents. 2004. PMID: 15194125 Review.
-
A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.J Antimicrob Chemother. 2007 Jul;60(1):132-5. doi: 10.1093/jac/dkm126. Epub 2007 May 4. J Antimicrob Chemother. 2007. PMID: 17483142
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous